News

Zacks Investment Research on MSN3h
Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus
The three most widely followed indexes in the United States have ended the past trading week on a positive note. The Nasdaq ...
Canadian Natural to report Q1 earnings: What's in the offing?
Canadian Natural Resources Limited is set to release first-quarter results on May 8. The Zacks Consensus Estimate for ...
Zacks Investment Research on MSN1h
Should You Retain Digital Realty Stock in Your Portfolio Now?
Digital Realty DLR is poised to gain from its unmatched global footprint of data centers with growing digital transformation, ...
Zacks.com on MSN1h
Analysts Estimate AlTi Global, Inc. (ALTI) to Report a Decline in Earnings: What to Look Out for
AlTi Global, Inc. (ALTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Twist Bioscience (TWST) reports Q2 loss, tops revenue estimates
Twist Bioscience came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.56.
TG Therapeutics: Q1 Earnings Snapshot
MORRISVILLE, N.Y. (AP) — MORRISVILLE, N.Y. (AP) — TG Therapeutics Inc. (TGTX) on Monday reported first-quarter earnings of $5.1 million. The Morrisville, New York-based company said it had net income ...
Zacks Value Investor Highlights: Berkshire Hathaway
Detailed price information for Berkshire Hathaway Cl B (BRK-B-N) from The Globe and Mail including charting and trades.
Axsome: Q1 Earnings Snapshot
(AXSM) on Monday reported a loss of $59.4 million in its first quarter. The New York-based company said it had a loss of $1.22 per share.